Abstract:Genetic engineering is one of the most advanced technologies in the world and can bring vast profits to developers by patenting resultant achievements. But genetic engineering must be based on original genetic materials. For obtaining such materials, developers travel around the world, especially to genetically rich areas in developing countries, to prospect for valuable genetic resources and bring back for research and patent derivate products. However a lot of disputes have arisen from such patents, such as the Enola patent dispute on Mexican traditional crop mayocoba bean and the patent dispute on sacred plant Ayahuasca between people and one U.S. Company. Indigenous people, who live in the origin areas of genetic resources for a long history, have established traditional and cultural genuine relation with some living species. These disputes revealed that some genetic engineering exploitation and patents based on certain species may be severely offensive against indigenous peoples spiritual, religious, or cultural traditions. Although genetic engineering achievements patentability has been argued for a long time, the TRIPs Agreement requirement and the worlds legislation trend, either in developed countries such as the U.S., European Union or in developing countries such as China, have indicated that genetic engineering products and processes are legitimately patentable. But some loophole exists in the patent acquisition procedure of current legislation, which allows such offensive patents to be granted. To prevent such offensive patents, one prior consents solution is proposed in this article, which requires genetic engineering developers to obtain prior consents from origin countries of genetic resources before they exploit these resources and patent derivate achievements. This solution is based on the Convention on Biological Diversity, which affirmed countrys sovereignty over their genetic resources and allowed countries to regulate and manage genetic resources in their territory. The Convention on Biological Diversity does not conflict with IPR legislation, in particular the TRIPs Agreement and the obligations under both treaties should be respected. The implementation of this proposed solution is based on the establishment of national genetic resources authority, which generally manages its countrys genetic resources and works as indigenous peoples representative with the authorization of state government. This solution should be implemented in three levels: domestically, transnationally and globally. Therefore, offensive genetic engineering patents could be prevented both by such authoritys examination and granting prior consents before developers access to genetic resources and by national patent administrations examination on prior consents proof from origin countrys authority before granting patents.

Data-mining Against Chinese Gene Patents

Legal Protection of China's Biotechnology Patents

Construction of the National Bio-Sequence Database of Chinese Patent

Patenting Human Genes: Chinese Academic Articles’ Portrayal of Gene Patents

Framing Ethical Concerns and Attitudes Towards Human Gene Patents in the Chinese Press

The Protection and Utilization of Transgenic Intellectual Property Rights in China:Problems and Suggestions

[Analysis of patent data of Panax notoginseng and enlightenment of industrial development]

Research on The Technological Innovation of Chinese Biomedicine Industry from Patent Information Perspective

Comparing nanotechnology landscapes in the US and China: a patent analysis perspective

Literature and Patent Analysis of the Cloning and Identification of Human Functional Genes in China

Exploring the Technological Changes of Green Agriculture in China: Evidence from Patent Data (1998–2021)

Competitive Landscape and Industry Prospects of Techniques in the Intersection of Computer Science and Genomics

The patent mining analysis method based on Chinese word segmentation

Research on Intellectual Property Right Protection of Genetic Resources in China Under Benefit-Sharing

Visual Research on Innovational Status of Chinese Biotechnological Pharmacy Industry:Patent Data Analysis Based on Scientometrics

Prior Consents: Preventing Offensive Genetic Engineering Patents Against Indigenous People's Rights

Publication Activity, Citation Impact and Bi-Directional Links Between Publications and Patents in Biotechnology

Scientific literature and patent information-based analysis of innovation situation in gene sequencing technologies

Discussion on the intellectual property risk and management of international cooperative scientific research from the perspective of human genetic resources protection

Biosimilar monoclonal antibodies in China: A patent review

Visualization of the Phenomenon of Cooperative Research and Development in China's Biopharmaceutical Industry——Based on Issued Patents among 2000～2009